ArticleFrontiers in oncology2021

How to Identify Patients at High Risk of Developing Nasal-Type, Extranodal Nature Killer/T-Cell Lymphoma-Associated Hemophagocytic Syndrome.

Na Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.